Original Research

Published on 17 Nov 2022

Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma

in Molecular and Cellular Oncology

Xiaoshan Hu
Liyi Guo
Guihong Liu
Zili Dai
Li Wang
Jian Zhang
Jun Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.997702

3,373 views
3 citations

Review

Published on 17 Nov 2022

Extracellular RNA as a kind of communication molecule and emerging cancer biomarker

in Molecular and Cellular Oncology

Danny Wu
Tao Tao
Emily A. Eshraghian
Peixu Lin
Zesong Li
Xiao Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.960072

4,016 views
13 citations

Original Research

Published on 16 Nov 2022

Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism

in Molecular and Cellular Oncology

Guisen Peng
Shuran Chen
Ni Zheng
Yuan Tang
Xu Su
Jing Wang
Rui Dong
Di Wu
Mingjie Hu
Yunli Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.996329

2,644 views
6 citations

Original Research

Published on 15 Nov 2022

Consistent downregulation of the cleft lip/palate-associated genes IRF6 and GRHL3 in carcinomas

in Molecular and Cellular Oncology

Ludovica Parisi
Carolin Mockenhaupt
Silvia Rihs
Farah Mansour
Christos Katsaros
Martin Degen

Frontiers in Oncology

doi 10.3389/fonc.2022.1023072

2,262 views
3 citations

Original Research

Published on 11 Nov 2022

Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma

in Molecular and Cellular Oncology

Deepika Dhawan
José A. Ramos-Vara
Sagar M. Utturkar
Audrey Ruple
Sarah A. Tersey
Jennifer B. Nelson
Bruce R. Cooper
Hock Gan Heng
Elaine A. Ostrander
Heidi G. Parker

Frontiers in Oncology

doi 10.3389/fonc.2022.1011969

7,698 views
11 citations

Mini Review

Published on 11 Nov 2022

Microfluidic vascular models of tumor cell extravasation

in Molecular and Cellular Oncology

Seunggyu Kim
Zhengpeng Wan
Jessie S. Jeon
Roger D. Kamm

Frontiers in Oncology

doi 10.3389/fonc.2022.1052192

6,272 views
13 citations

Original Research

Published on 10 Nov 2022

A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)

in Molecular and Cellular Oncology

Sólrún Melkorka Maggadóttir
Gunnar Kvalheim
Patrik Wernhoff
Stein Sæbøe-Larssen
Mona-Elisabeth Revheim
Dag Josefsen
Sébastien Wälchli
Åslaug Helland
Else Marit Inderberg

Frontiers in Oncology

doi 10.3389/fonc.2022.1031232

2,579 views

Review

Published on 10 Nov 2022

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma

in Molecular and Cellular Oncology

Raymond S. Traweek
Brandon M. Cope
Christina L. Roland
Emily Z. Keung
Elise F. Nassif
Derek J. Erstad

Frontiers in Oncology

doi 10.3389/fonc.2022.1006959

10,615 views
23 citations

Original Research

Published on 10 Nov 2022

Four circadian rhythm-related genes predict incidence and prognosis in hepatocellular carcinoma

in Molecular and Cellular Oncology

Zhenyu Wu
Hao Hu
Qiang Zhang
Tengfei Wang
Huixing Li
Yugang Qin
Xiangnan Ai
Wen Yi
Xiaojun Wei
Wei Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.937403

2,240 views
5 citations

Case Report

Published on 10 Nov 2022

Case report: Almonertinib in combination with bevacizumab for leptomeningeal metastases from epidermal growth factor receptor-mutation non-small cell lung cancer: Case series

in Molecular and Cellular Oncology

Yuhai Zhang
Meilin Zhang
Wanwan Cheng
Shencun Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.1040450

1,824 views
3 citations

Original Research

Published on 10 Nov 2022

Expanding the molecular spectrum of tenosynovial giant cell tumors

in Molecular and Cellular Oncology

Thibault Gauduchon
Helene Vanacker
Daniel Pissaloux
Philippe Cassier
Armelle Dufresne
Marie Karanian
Alexandra Meurgey
Amine Bouhamama
François Gouin
Isabelle Ray-Coquard

Frontiers in Oncology

doi 10.3389/fonc.2022.1012527

2,417 views
7 citations

Original Research

Published on 10 Nov 2022

Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma

in Molecular and Cellular Oncology

Nguyen Van Hiep
Wei-Lun Sun
Po-Hao Feng
Cheng-Wei Lin
Kuan-Yuan Chen
Ching-Shan Luo
Le Ngoc Dung
Hoang Van Quyet
Sheng-Ming Wu
Kang-Yun Lee

Frontiers in Oncology

doi 10.3389/fonc.2022.963896

4,188 views
2 citations

Original Research

Published on 09 Nov 2022

Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach

in Molecular and Cellular Oncology

Xiaobin Fei
Songbai Liu
Peng Liu
Xing Wang
Changhao Zhu
Junyi Hou
Junzhe Cai
Yaozhen Pan

Frontiers in Oncology

doi 10.3389/fonc.2022.1043161

2,248 views
2 citations

Original Research

Published on 07 Nov 2022

Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers

in Molecular and Cellular Oncology

Zhenfen Li
Zhangya Pu
Ziyue Yang
Yuanyuan Zhu
Ying Deng
Ning Li
Fang Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.971618

2,502 views
3 citations

Editorial

Published on 07 Nov 2022

Editorial: Hallmark of cancer: Resisting cell death

in Molecular and Cellular Oncology

Yichao Zhu
Risheng Yang
Jacqueline H. Law
Muhammad Khan
Kenneth W. Yip
Qiang Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.1069947

4,304 views
3 citations

Original Research

Published on 07 Nov 2022

Homotypic cell-in-cell structures as an adverse prognostic predictor of hepatocellular carcinoma

in Molecular and Cellular Oncology

Ruizhi Wang
Yichao Zhu
Hao Zhong
Xinyue Gao
Qiang Sun
Meifang He

Frontiers in Oncology

doi 10.3389/fonc.2022.1007305

1,581 views
4 citations

Navigation group

Articles

Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma

Extracellular RNA as a kind of communication molecule and emerging cancer biomarker

Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism

Consistent downregulation of the cleft lip/palate-associated genes IRF6 and GRHL3 in carcinomas

Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma

Microfluidic vascular models of tumor cell extravasation

A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma

Four circadian rhythm-related genes predict incidence and prognosis in hepatocellular carcinoma

Case report: Almonertinib in combination with bevacizumab for leptomeningeal metastases from epidermal growth factor receptor-mutation non-small cell lung cancer: Case series

Expanding the molecular spectrum of tenosynovial giant cell tumors

Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma

Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach

Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers

Editorial: Hallmark of cancer: Resisting cell death

Homotypic cell-in-cell structures as an adverse prognostic predictor of hepatocellular carcinoma